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Summary
Weibel-Palade bodies are the 1–5 mm long rod-shaped
storage organelles of endothelial cells. We have inves-
tigated the determinants and functional significance of
this shape. We find that the folding of the hemostatic
protein von Willebrand’s factor (VWF) into tubules un-
derpins the rod-like shape of Weibel-Palade bodies.
Further, while the propeptide and the N-terminal do-
mains of mature VWF are sufficient to form tubules,
their maintenance relies on a pH-dependent interac-
tion between the two. We show that the tubular confor-
mation of VWF is essential for a rapid unfurling of
100mm long, platelet-catching VWF filaments when ex-
posed to neutral pH after exocytosis in cell culture and
in living blood vessels. If tubules are disassembled
prior to exocytosis, then short or tangled filaments
are released and platelet recruitment is reduced.
Thus, a 100-fold compaction of VWF into tubules deter-
mines the unique shape of Weibel-Palade bodies and
is critical to this protein’s hemostatic function.
Introduction
Many proteins are stored within the secretory granules
of cells, to be released only upon stimulation-dependent
exocytosis. Despite the very different functions carried
out by these hormones, zymogens, and other secretory
proteins, their storage organelles are generally variants
on a sphere, presumably reflecting the high storage ca-
pacity of this shape. However, within the granules, the
content exhibits a wide variety of structures—from
amorphous to tubular to crystalline. Does the storage
format of these proteins simply reflect the effects of con-
centrating the content as much as possible to maximize
*Correspondence: d.cutler@ucl.ac.ukstorage, or is there any postexocytic functional signifi-
cance to these structures? To address this general
question, we have examined the granules of endothelial
cells that contain a tubular cargo.
The hemostatic protein von Willebrand’s factor (VWF)
is stored within the uniquely rod-shaped Weibel-Palade
bodies (WPBs) (Wagner et al., 1982; Weibel and Palade,
1964) in endothelial cells. After secretagogue stimula-
tion, WPBs undergo exocytosis, releasing ultralong
(100 mm in average) VWF filaments that capture platelets
along their lengths (Andre et al., 2000; Dong et al., 2002).
Subsequent activation and aggregation of platelets
cause the formation of a hemostatic plug (Ruggeri,
2003b). Failure to secrete ultralong VWF filaments upon
WPB exocytosis, as in von Willebrand’s disease, in
which VWF is mutated, leads to excessive bleeding
(Ruggeri, 2003a; Sadler, 2005).
VWF filament formation in endothelial cells is a com-
plex process (Michaux and Cutler, 2004; Sadler, 1998;
van Mourik et al., 2002). First, in the ER, disulphide
bonds form between C-terminal domains, causing di-
merization. Second, in the Golgi, disulphide bonds are
formed between the N-terminal D0-D3 domains of the di-
mers, leading to multimerization of mature VWF. Before
or during N-terminal bonding, Furin-dependent cleav-
age of the 741 amino acid propeptide occurs (Wise
et al., 1990). This process ultimately generates a very
large multimer composed only of mature VWF; the pro-
peptide acts as a cofactor supporting N-terminal disul-
phide bond formation and remains noncovalently asso-
ciated with mature VWF in a 1:1 stoichiometry in WPBs
(Ewenstein et al., 1987; Wagner et al., 1987). The VWF
multimers then adopt a tubular conformation and are
stored in rigid, rod-like WPBs of 1–5 mm (Wagner et al.,
1982; Weibel and Palade, 1964). While the propeptide
is rapidly dispersed in the bloodstream at exocytosis
(Hannah et al., 2005), the multimeric filaments unfurl rap-
idly, within 15 s of stimulation in mice (Andre et al., 2000).
Organizing them into a comparatively small organelle,
yet preventing their entanglement inside WPBs prior to
secretion and upon unfurling, must require sophisti-
cated packing. We hypothesized that tubulation might
be required for efficient unfurling and the subsequent
hemostatic function of VWF.
We first established a strict correlation between WPB
elongation and VWF tubulation. We show that it involves
a pH-dependent interaction between the propeptide and
the first three domains of the mature protein and does
not require multimerization, confirming that tubulation
is independent of multimerization (Wagner et al., 1991).
Second, we demonstrate that the compact storage of
the filaments requires an acidic pH and an interaction
with the propeptide. Finally, we show that both tubular
storage and multimerization are necessary for the rapid
unfurling of the long VWF filaments from stimulated en-
dothelial cells in culture and in laser-injured cremaster
venules in mice, as tested by their ability to recruit plate-
lets. We conclude that the unusual elongated shape of
WPBs is dictated by VWF folding into the tubules that
are necessary for correct and rapid unfurling of the
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224Figure 1. The D1-A1 Domains of VWF Are
Both Necessary and Sufficient for VWF Tubu-
lation and WPB Elongation
(A) VWF is drawn roughly to scale, showing its
domain structure; the constructs used are
shown underneath. SP, signal peptide; Pro,
propeptide; Dpro, mature VWF. The star
within Y87S indicates the location of this tyro-
sine-to-serine mutation. The furin cleavage
site is indicated by an arrowhead.
(B) Light and electron microscopic analyses
of the VWF-positive structures produced by
the various constructs. Apart from the up-
per-left panel (HUVECs), HEK293 cells were
nucleofected with the indicated VWF con-
struct; 2 days later, they were fixed and
stained for mature VWF or the propeptide
and were analyzed by light microscopy. In
the two central panels, cells were analyzed
by electron microscopy. The insets are en-
largements of the regions boxed with a
dashed line. Elongated WPBs can be ob-
served with WT, D1-A1, D1-D3, and Pro+Dpro
constructs, but only round, VWF-positive
structures are observed after Pro, Dpro, or
Y87S constructs. Scale bars represent
10 mm (100 nm in electron micrographs).
(C) The size of elongated (light gray) and
round (dark gray) WPBs was measured after
expression of WT-VWF, D1-A1, and D1-D3.
Bars represent mean 6 standard deviation
(nR 100 WPBs for each bar).
(D) HUVECs were nucleofected with Y87S at
low or high concentration, left for 24 hr, and
stained with anti-VWF. Shorter WPBs can
be observed in the lower panel. The scale
bar represents 10 mm.ultralong VWF filaments, and therefore that the storage
format of granule cargo does indeed matter.
Results
The D1-A1 Domains Are Essential to VWF
Tubulation and WPB Elongation
In straight WPBs, the VWF tubules generally run from
one end of the organelle to the other, strongly suggest-
ing that WPB elongation is driven by the presence of in-
ternal VWF tubules (Figure S1; see the Supplemental
Data available with this article online). Having previously
recapitulated the formation of functional WPBs in
HEK293 cells (Michaux et al., 2003), we used this system
to determine the VWF domain(s) responsible for WPB
elongation. We expressed several VWF deletions and
a human mutant VWF that causes severe von Wille-brand’s disease (Rosenberg et al., 2002) in HEK293 cells
(Figures 1A and 1B).
Analysis of deletions revealed that expression of either
the propeptide (D1 and D2 domains) or mature VWF (D0 to
CK domains) under identical conditions triggers the for-
mation of round, VWF-positive structures alone. Coex-
pression of both constructs in trans led to the formation
of many elongated WPBs, indicating that both are neces-
sary for WPB elongation. After expressed VWF was re-
duced to the D1-D3 domains, most WPBs observed
were round; however, a few were slightly elongated
(note that the picture was obtained with a c-myc-tagged
D1-D3, but that slightly elongated WPBs were also seen
after expression of an untagged D1-D3 construct or a
GFP-tagged D1-D3). In contrast, almost all WPBs were
elongated after expression of a truncated VWF contain-
ing D1-A1 domains. Measuring the length of elongated
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225Figure 2. VWF Tubulation and WPB Elonga-
tion Are Dependent on an Acidic pH
(A–F) HUVECs were stained for VWF or ob-
served by electron microscopy. (C and D)
Monensin, (E) NH4Cl, or (F) chloroquine
were applied for 60 min and altered the elon-
gated shape of WPBs from HUVECs. Arrow-
heads (B–D) point to WPBs; note that in (D)
the tubular organization of VWF has been dis-
rupted by monensin, and that WPBs become
spherical. Scale bars represent 10 mm (100
nm in [B] and [D]).WPBs confirmed that D1-A1 and WT-VWF expression
triggered the formation of WPBs significantly longer
than those formed after D1-D3 expression (Figure 1C),
while the round WPBs seen in varying numbers after ex-
pression of all constructs have similar smaller sizes.
To confirm that genuine VWF tubules can be made
from the N-terminal half of VWF alone, the ultrastructure
of WPBs after D1-A1 expression was examined by EM
and was found to be indistinguishable from that found
after WT-VWF expression (Figure 1B). To further test
the role of the propeptide in VWF tubulation, we also ex-
pressed the Y87S variant in both HEK293 cells (Fig-
ure 1B) and in human umbilical vein endothelial cells
(HUVECs) (Figure 1D). Expression of Y87S led to the for-
mation of round WPBs in HEK293 cells. Transfecting 625
ng per 3.5 cm dish of this construct in HUVECs had no
effect on WPB formation or length, but when 25 mg
was transfected, the WPBs were much shorter. This dif-
ference clearly indicates that the mutant propeptide can
have a dominant effect on WPB shape, probably by dis-
rupting the VWF tubules.
We conclude that both the propeptide and D0-D3-A1
domains of mature VWF are required to store VWF as tu-
bules, and that these correlate with WPB elongation.
Maintenance of VWF Tubulation Depends
on the Intraorganelle Environment and Is
Indeed Responsible for WPB Elongation
WPBs form at the trans-Golgi network (TGN), at which
point the pH falls, suggesting that an acidic pH might
be needed for tubule formation and thus WPB shape.
To test this hypothesis, we incubated HUVECs in the
presence of monensin (Figures 2C and 2D), NH4Cl
(Figure 2E), or chloroquine (Figure 2F), all of which neu-
tralize the pH of acidic organelles. These treatments
caused most WPBs to become round within 1 hr (Fig-
ure 2), and monensin had the strongest and fastest ef-
fect (Figure S2A). We were unable to detect tubules by
electron microscopy of HUVECs treated with monensinfor 1 hr (Figure 1D). We also tested the effect of monen-
sin on WPBs generated in HEK293 cells after expression
of the D1-A1 truncation and found that they also become
round after a 1 hr treatment (Figure S2B). We conclude
that VWF tubulation underpins the elongated shape of
WPBs, and that both are dependent on an acidic pH.
To determine the pH within WPBs, we used a functional
assay, based on this change in WPB shape. Analysis of
HUVECs incubated with the ionophore nigericin buff-
ered at various pHs revealed that WPBs are predomi-
nantly round at pH 7, mostly elongated at pH 6 or pH
5.5, and exhibit an intermediate phenotype at pH 6.5
(Figure S3). This suggests that the pH within WPBs is be-
low 6.5, but probably above pH 6 (Figure S3, legend),
and confirms that an acidic pH is crucial for VWF tubula-
tion.
VWF Tubulation Is Essential for VWF Unfurling
Upon exocytosis, VWF in WPBs is exposed to blood (pH
7.4), at which point it rapidly unfurls from the compact
tubular storage format into filaments 100 times longer
than the WPBs. To determine how that physiological
switch in pH relates to the rounding of monensin-treated
WPBs in cultured cells, we treated HUVECs with the de-
tergent Triton X-100 (TX-100), which removed the con-
straining membrane from around VWF and allowed
changes in the folding of VWF to be monitored by immu-
nofluorescence microscopy. To observe intermediates
of VWF unfolding, we performed this treatment on ice
at various pHs dictated by our findings described above.
At pH 5.6, there was very little change in VWF staining,
even after 20 min of detergent treatment, such that
a very compact shape, reminiscent of the rod-like
WPBs, could be recognized (Figures 3A and 3B). Treat-
ment at pH 6.4 gave an intermediate, dispersed pheno-
type (Figures 3C and 3D), and we were able to clearly see
a VWF filament coming out of what looked like a single
WPB (Figure 3D0). However, treatment at pH 7.2, mim-
icking the environment after exocytosis, led to a loss of
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of mature VWF (Figures 3E and 3F). Furthermore, we ob-
served the formation of short filaments after detergent
treatment of HUVECs at neutral pH after only 5 min
(Figure 3E), and long filaments of 50 mm or more were
common after 20 min (Figure 3F). In contrast, filaments
were only very rarely seen when HUVECs were treated
with detergent at acidic pH.
We hypothesized that storage of VWF as tubules
avoids tangling the long VWF filaments during biogene-
sis: as with carefully coiled ropes, a tubular packing
should allow for an easy transition from compressed to
elongated VWF and could thus be a prerequisite for
Figure 3. Storage of VWF as Tubules Promotes Its Efficient Disper-
sion
(A–F) HUVECs were stained for VWF during processing for immuno-
fluorescence microscopy. Treatment with TX-100 (time is indicated
above the panels) at an (A and B) acidic pH had little effect, while at
a (C–D0) less acidic or at a (E and F) neutral pH it allows VWF disper-
sion and unfurling of long filaments (arrowheads in [C], [D0], [E], and
[F]).
(G and H) Monensin treatment followed by TX-100 at a neutral pH
prevents VWF dispersion, and unfurled filaments were rarely ob-
served (arrowhead in [H]).
(I and J) HUVECs were stained for mature VWF (VWF; red) and the
propeptide (Pro; green) after TX-100 treatment. Both proteins coloc-
alize at (I) acidic pH; however, the propeptide is released at (J) neu-
tral pH, while VWF dispersion can be observed.
In all panels, the scale bars represent 10 mm.VWF dispersion and the rapid formation of long filaments
at exocytosis. We therefore pretreated HUVECs with
monensin for 15 min, followed by TX-100 treatment at
pH 7.2. Comparing this (Figures 3G and 3H) with mock-
treated cells bathed in TX-100 at pH 7.2 (Figures 3E
and 3F), it was clear that both VWF dispersion and the
ability to unfurl into long filaments were severely affected
by treatment with monensin. We conclude that VWF tu-
bulation is necessary for the unfolding of VWF when
the membrane is removed, even in static conditions.
The propeptide is noncovalently associated with VWF
multimers in WPBs (Ewenstein et al., 1987; Wagner
et al., 1987), and its binding to VWF multimers is pH
and calcium dependent (Vischer and Wagner, 1994).
To analyze the role of the propeptide in VWF compac-
tion, we determined its localization during detergent
treatment. At pH 5.6, the propeptide exactly colocalized
with compact, mature VWF, but, at pH 7.2, it was no lon-
ger associated with the dispersed VWF (Figures 3I and
3J). This implies that the compact, elongated shape of
WPBs relies on a pH-dependent interaction between
the propeptide and mature VWF. Together with our
data from the Y87S mutant, this strongly suggests a di-
rect role for the propeptide in VWF compaction into tu-
bules. Increasing or decreasing the calcium concentra-
tion during detergent addition at a neutral pH did not
have a significant effect on VWF dispersion (data not
shown).
VWF Multimerization and Dispersion
Since the interactions within VWF leading to tubulation
and to multimerization are closely related, we also tested
the role of multimerization in the maintenance of WPB
elongation by incubating HUVECs with 20 mM DTT for
2 hr. We could not identify any striking change in the
shape of WPBs, suggesting that tubulation was not af-
fected by the disruption of disulphide bonds (Figures
4A and 4B). Surprisingly, when these cells were
Figure 4. Maintenance of WPB Elongation Does Not Require Multi-
merization
(A–F) HUVECs were stained for VWF. (A) Normal WPBs are elon-
gated. (C and E) Treatment with the detergent TX-100 at a neutral
pH induces VWF dispersion. (B) DTT treatment (20 mM for 2 hr)
does not affect WPB shape, and, (D and F) when followed by TX-
100 at a neutral pH, it completely prevents any VWF dispersion.
The scale bars represent 10 mm.
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with 1% TX-100, we still observed no change in VWF
staining (Figures 4D and 4F), to the point that these cells
were indistinguishable from untreated HUVECs (Fig-
ure 4A). Although long filaments were not expected, as
these are formed by multimers, we detected no disper-
sion at all. We conclude that the expansion of VWF is de-
pendent on its disulphide bonds, but that tubulation itself
is not affected.
Tubular Storage of VWF Is Required for
the Formation of Long, Platelet-Recruiting
Filaments after Exocytosis In Vitro
Our data led to the hypothesis that the tubular structure
of VWF is needed to generate long VWF filaments after
exocytosis. In flow chamber experiments, it has been
shown that these long filaments can recruit platelets af-
ter exocytosis (Dong et al., 2002), and we used this sys-
tem to further test our hypothesis. HUVECs were placed
in a parallel-plate flow chamber and were perfused with
culture medium and histamine (100 mM) at a constant
wall shear stress of 0.25 Pa, mimicking conditions within
venules (Dong et al., 2002). Histamine was perfused for 1
min, followed by histamine plus purified platelets (1 3
108/ml). Less than 1 min after platelet addition, platelets
started to attach to VWF filaments (Movie S1). On aver-
age, 9.4% of stimulated HUVECs were able to generate
VWF filaments that were 94 6 11 mm long and carried
15.4 6 1.7 platelets (Figures 5A and 5C–5E; Movie S2).
We then used monensin to disassemble the VWF tu-
bules within the WPBs of the cells before placing them
in the parallel-plate flow chamber. After drug treatment,
only 6.3% of the cells generated VWF filaments; further-
more, we observed a 50% decrease in the average num-
ber of platelets per filament (7.9 6 1) and a filament
length of 59 6 6 mm (Figures 5B–5E; Movie S3). Impor-
tantly, the greatest effect is on the longest filaments
(above 150 mm), which essentially disappear. Quantita-
tion by ELISA showed that monensin does not reduce
regulated secretion of VWF (Figure 5F). We also found
that the number of platelets bound per micrometer of
VWF filament decreased only marginally in monensin-
treated cells (Figure S4). Thus, monensin does not affect
VWF secretion nor its affinity for platelets, but only its
ability to unfurl in long, platelet-recruiting filaments.
Monensin Treatment Impairs the Rapid Unfurling
of Platelet-Recruiting VWF Filaments after
Exocytosis in Mouse Venules
We next investigated the effect of monensin in vivo. In
control mice, laser injury to venules induced platelet
strings originating from the site of injury and extending
up to 250 mm downstream within less than 10 s in general
and after only 1–2 s in some instances (Figures 6A, 6B,
and 6E; Movie S4). Mice pretreated with monensin be-
fore surgery (100 mM, 200 ml intrascrotal for 1 hr) gener-
ated strings that were three times shorter than those in
control mice (Figures 6C and 6E). Strings were transient
in nature and usually disappeared from venules within
30 s of injury (Figure 6F), which is consistent with a pre-
vious in vitro report (Dong et al., 2002). In both control
and monensin-treated vessels, platelets appeared to
translocate along the string in the direction of flow rather
than being stably adherent.In separate experiments, we increased exposure to
monensin by superfusing it directly onto the cremaster
muscle for 30 min (100 mM, 8 ml/min) prior to laser injury.
In these experiments, we routinely observed tangled
platelet strings (Figure 6D; Movie S5), which resembled
balls that were distinct from thrombi, required only
weak laser injury, and formed almost immediately.
Figure 5. Disassembly of VWF Tubules Reduces the Length of
Platelet-Recruiting Filaments from HUVECs Stimulated under Flow
(A and B) Untreated (2 Mon) or monensin-treated (+ Mon) HUVECs
were incorporated into a parallel plate flow chamber. Histamine, fol-
lowed 1 min later by histamine plus platelets, was perfused across
the HUVECs at a wall shear stress of 0.25 Pa for 10 min, during which
formation of platelet strings was recorded. Three consecutive fields
were captured to create the pictures. Arrowheads point to the origin
of individual platelet strings. ‘‘Levels’’ were adjusted in Photoshop to
enhance platelet string visibility (arrowheads). The scale bar repre-
sents 50 mm.
(C) A total of 50 fields were analyzed for the number of cells releasing
at least 1 filament. Bars indicate the percentage 6 standard devia-
tion (n = 4 experiments).
(D and E) All observable individual strings of platelets were analyzed
for (D) length and (E) number of attached platelets. Numbers in (D)
and bars in (E) indicate the mean 6 standard deviation (n = 4 exper-
iments).
(F) A VWF-ELISA was performed after a 10 min stimulation or mock
stimulation with histamine of untreated or monensin-treated cells.
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228Figure 6. Monensin Treatment Disrupts the
Formation of Injury-Induced Platelet Strings
in Mice Venules
(A–D) (A and B) Control or (C and D) monen-
sin-treated mouse cremasters were ob-
served for platelet string formation after laser
injury. Flow is from left to right. Arrows point
to the position of laser injury; black arrow-
heads point to individual platelets or groups
of platelets along the string; white arrow-
heads indicate rolling leukocytes. ‘‘Levels’’
were adjusted in Photoshop to enhance
platelet visibility. (A and B) Laser-induced
platelet interactions in a postcapillary venule
of a control mouse. (A) Platelets are visible
as black punctae. (B) FITC-CD41-labeled
platelets were infused to confirm the identity
of the black punctae. The image is a maximum
intensity projection of 100 slices of a stack
collected at 3 slices per second. Dotted lines
indicate the approximate locations of vessel
walls. (C and D) Laser-induced platelet inter-
action in a mouse treated with monensin by
(C) instrascrotal pretreatment (three platelets are visible as white punctae in a row) or (D) direct superfusion (super-stable tangled knot of plate-
lets). In all panels, scale bars represent 10 mm.
(E and F) (E) Length and (F) stability of individual platelet strings were determined in 10–19 venules from 5 untreated and 4 monensin-pretreated
(instrascrotal) mice. This does not take into account the data involving tangled platelet balls from direct superfusion. The numbers indicate the
mean.Approximately 50% of these tangles washed immedi-
ately downstream; however, those remaining attached
were still present after 1 hr.
The observation of leukocytes rolling on the endothe-
lial surface in monensin-treated mice (Figures 6C and
6D; see also Movie S5, in which three leukocytes can
be observed starting to roll only after the laser-induced
injury) provided an internal control for WPB exocytosis
in these experiments; this rolling reflects the appear-
ance of the leukocyte receptor P-selectin (Moore et al.,
1995).
Discussion
Rod-shaped WPBs are a classic hallmark of endothelial
cells. We find that the elongated shape of WPBs de-
pends on the ability of VWF to form tubules. We also
show that both the propeptide and the N-terminal D0-
A1 domains of mature VWF are necessary and sufficient
for tubule formation. The maintenance of tubules, and
thus WPB shape, is also dependent on the low pH that
is essential for the propeptide to bind mature VWF. We
find that the rapid unfurling, after exocytosis, of the
long filaments that permit initial recruitment of platelets
at sites of endothelial cell injury correlates with the stor-
age of VWF in tubules. Thus, the shape of this organelle
is essential to its cargo’s function because the hemo-
static function of VWF depends on its storage in tubules.
The storage format of a cargo can therefore directly in-
fluence the function of that cargo after exocytosis.
Whether the fraction of platelet binding dependent on
tubular storage of VWF is needed to avoid bleeding is
currently unclear. For example, chloroquine, widely
used for prevention and treatment of malaria and (as
an anti-inflammatory agent) several auto-immune dis-
eases, has the side effect of causing bleeding. Based
on the data presented here, we speculate that this re-
flects the predicted decreased ability to recruit plateletsto VWF. However, chloroquine also has direct effects on
platelets, precluding a simple interpretation.
pH and the Maintenance of Tubulation
The importance of pH to VWF tubulation was revealed by
using four different treatments to neutralize the intra-
WPB environment. After monensin treatment, WPBs
lack the internal striations that represent VWF tubules
in longitudinal section, and this effect is not reversible
(Lui-Roberts et al., 2005). Monensin and other pH-alter-
ing drugs have been shown in the past to interfere with
VWF multimerization and glycosylation (Vischer and
Wagner, 1994; Wagner et al., 1985, 1986), but the incuba-
tion times used were very long (several days), and the ef-
fects were likely due to the consequences of neutraliza-
tion of pH within the Golgi apparatus and the TGN,
blocking the formation of new multimers. We used short
incubation times to examine the effect of monensin on
preexisting WPBs (we estimate that 95% of WPBs af-
fected by monensin were formed before the treatment)
that will not affect VWF multimerization, since this is de-
pendent on the formation of disulphide bonds in the ER
and the Golgi. Further, if neutralizing the pH in WPBs
were to disassemble multimers, then only monomers
would be seen in plasma. In fact, proteolysis by
ADAMTS13 is required to reduce the size of VWF multi-
mers to those seen in blood (Dong et al., 2002).
Our results show that an acidic pH is required for sta-
bilization of VWF tubules, and that the shape of WPBs is
closely related to the tubular conformation of VWF. Con-
sistent with these results, removal of the limiting mem-
branes by treatment with detergent results in VWF dis-
persion at a neutral pH, but retention of a very compact
shape when an acidic medium is used with the deter-
gent. These results correlate with our finding that the
pH within WPBs is likely to be between 6 and 6.5. We
conclude that VWF tubulation, dependent on noncova-
lent interactions, underpins WPB elongation.
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To determine which domains of VWF are important for
elongation, we used heterologous expression of VWF
in HEK293 cells (Michaux et al., 2003). We could not de-
tect elongated WPBs after expression of either the pro-
peptide or mature VWF, indicating that domains in both
peptides are required for tubulation. We also found that
expression of a truncated protein comprising the pro-
peptide and the D0-A1 domains of mature VWF is suffi-
cient to allow formation and storage of monensin-sensi-
tive tubules in elongated WPBs. Since the truncated
protein cannot multimerize, this indicates that an intact
propeptide and the D0-A1 domains are sufficient for
VWF tubulation, independent of multimerization. This
surprising result—that tubulation and multimerization
are independent—is confirmed by our data from DTT
treatment.
Among the mutations we have expressed in HEK293
cells, only Y87S affects WPB elongation and thus tubu-
lation; but, as it also completely blocks multimerization,
we have not been able to separate these two processes
on the basis of human disease-causing mutations. In-
deed, we would now argue that mutations affecting
the propeptide or the D0-A1 domains of mature VWF
might not only directly affect platelet binding, but also
tubulation, thereby indirectly interfering with VWF func-
tion in platelet recruitment.
VWF Storage Format and Function
Because we have shown that monensin does not signif-
icantly affect VWF secretion, affinity for platelets, or fila-
ment stability—as long as it is not a tangle—we con-
clude that its only effect is to disrupt the tubular
conformation of VWF inside WPBs. The simplest expla-
nation for VWF storage in tubules is that it prevents en-
tanglement of the multimer and allows for its rapid un-
furling. If, instead, it is kept in a disorganized storage
format, as after monensin treatment, then, upon exocy-
tosis, the VWF multimer cannot unfurl properly, but
rather generates a short or tangled filament. From the
flow cell experiments, by combining the percentage of
cells able to generate a filament with the average num-
ber of platelets carried by these filaments, we find that
100 HUVECs will capture 145 platelets (i.e., multiplying
9.4 cells generating filaments by the average 15.4 plate-
lets captured by a given filament), compared to only 50
platelets for 100 monensin-treated HUVECs—a 65% de-
crease in VWF efficiency. That some VWF filaments can
undergo partial extension after monensin treatment
probably reflects that some unfolding, possibly aided
by flow, can occur when tangles and knots have been
randomly avoided. While this leads to an apparent mis-
match between the dramatic effects of monensin on
shape and the more partial effect on filament length,
these simple quantitative analyses may underestimate
the effects of treatment, since monensin has its greatest
effect on the longest strings, which are thought to be
disproportionately important to VWF function.
The surprising stability of the monensin-induced VWF
tangles indicates that they are resistant to the metallo-
protease ADAMTS13; presumably, an orderly string un-
der flow facilitates exposure of the cleavage site to the
protease. ADAMTS13 cleaves the long VWF multimers
within 30–60 s (Dong et al., 2002) to prevent anarchicclotting and platelet depletion, leading to bleeding. In-
deed, mutations in ADAMTS13 are responsible for the
rare bleeding disorder thrombotic thrombocytopenic
purpura (Levy et al., 2001). The dangerous ultrathrombo-
genic potential of the long VWF filaments is therefore
normally strictly limited to the site of injury. But, it makes
it even more crucial to unfurl as long a filament as possi-
ble very rapidly so as to recruit the maximum number of
platelets in the minimum time. We therefore hypothesize
that VWF mutations affecting tubulation could induce
thrombotic thrombocytopenic purpura in an ADAMTS13
wild-type context as well as von Willebrand’s disease.
VWF Tubules Might Be Constrained Springs
Cargo condensation is central to secretory granule bio-
genesis, but we now argue that it can be more than sim-
ply a device to maximize storage; it can also be essential
to a cargo’s physiological function after exocytosis. VWF
unfurling is a very rapid process: in laser-injured mice,
we observed some platelet strings or tangles only 1–2 s
after the first hit, faster than the 15 s delay reported after
stimulation with the calcium ionophore A23187 (Andre
et al., 2000). During this time, events that may include
signal transduction, docking of WPBs, fusion of the
membranes, unfurling of the VWF filament, and recruit-
ment of platelets, must all occur, which leaves a very
short time for a 100-fold expansion of the VWF multimer.
It is possible that the filament is pulled out by fluid flow-
ing past the fusion pore, rather than pushed out by
VWF unfolding driven by the pH switch. However, we
would argue that the appearance of filaments in our
static immunofluorescence experiments, even when
done on ice, strongly argues that even if it makes a con-
tribution, flow cannot provide a full explanation for fila-
ment extension.
The structure of VWF in the tubules is not known, ex-
cept that they appear in electron microscopy to form hol-
low cylinders (Figure S1B) and that they are rigid (data
not shown). Furthermore, in solution, VWF multimers
can adopt a random coiled conformation (Fowler et al.,
1985; Slayter et al., 1985). Under flow, the filaments
stretch or contract as flow is increased or decreased
(Dong et al., 2002; our unpublished data). On the bases
of these data, we propose a speculative model: we hy-
pothesize that the tubules are VWF multimers coiled
into a constrained spring at low pH, and that the propep-
tide is at least partly responsible for this constraint.
The propeptide, which is rapidly lost after secretion
(Hannah et al., 2005) and has no known physiological
function in the blood, was thought only to be required
as an oxidoreductase during multimerization (Purvis
and Sadler, 2004; Vischer and Wagner, 1994) and for
storage of mature VWF (Haberichter et al., 2000, 2003).
We now show that the interaction between the propep-
tide and mature VWF in WPBs correlates with their elon-
gated shape and the release of the filaments when the
pH is raised. This is consistent with a previous report
showing that the propeptide is released from binding
to mature VWF upon exocytosis at neutral, but not
acidic, pH (Vischer and Wagner, 1994). We therefore
propose that a pH-dependent interaction of the propep-
tide with VWF in WPBs is required to constrain VWF into
a spring-like structure, and that, upon exocytosis, pro-
peptide dissociation allows filament unfurling (Figure 7).
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might therefore be a necessity rather than a default
fate. The most likely explanation of the monensin effect
is that of a detachment of the propeptide leading to
a premature unfurling of the VWF filament inside WPBs.
Structural studies of the tubules are also essential to
better understand how VWF unfurling might be affected
by VWF mutations and cause bleeding in an unexpected
manner. We also show here that at least one drug used
to treat several diseases has an effect on VWF tubules,
and this could be true of any other drug altering intraor-
ganellar pH, potentially explaining bleeding side effects,
but also perhaps providing a new way of controlling
VWF physiological function in hemostasis without af-
fecting the inflammatory function of P-selectin.
Experimental Procedures
Cell Culture, Transfection, and Reagents
Human umbilical vein endothelial cells (HUVEC) were purchased
from Cascade Biologicals (Portland, OR). The cells were grown in
M199 (GIBCO-BRL, Grand Island, NY) with 20% fetal calf serum (Hy-
clone, Logan, UT), 10 U/ml heparin (Sigma, St. Louis, MO), 50 mg/ml
gentamicin, and 30 mg/ml endothelial cell growth supplement
(Sigma). HEK293 cells were provided by BD Biosciences (Oxon,
United Kingdom) and were grown in a-minimum essential medium
(a-MEM) (Life Technologies, Paisley, United Kingdom), 10% fetal
calf serum, and 50 mg/ml gentamicin (Life Technologies). Cells
were transiently transfected by Nucleofection (Amaxa, Cologne,
Germany) according to the manufacturer’s instructions.
Monensin (Sigma) was used at a 10 mM final concentration for 1 hr
unless stated otherwise and was diluted in growth medium, saline,
or in superfusion buffer. NH4Cl, nigericin, and chloroquine (Sigma)
were used, respectively, at 20 mM, 10 mM, and 100 mM final concen-
tration in growth medium. Triton X-100 (Sigma) was used at 1% in
PBS after pH adjustment. The detergent was applied on ice for
20 min. DTT (Sigma) was used at 20 mM for 2 hr.
Expression Vectors
VWF constructs Pro and Dpro have been described (Haberichter
et al., 2000), as has the Y87S VWF variant (Rosenberg et al., 2002).
The D1-D3 construct was obtained by PCR and subcloning with
the template pVW198.1 (Kroner et al., 1991). A 1302 base pair PCR
product was generated with the primer s-VWF-2373 (50-GTGCCAG
AACTATGACCTGGAGTGCATGAGCATGGGCTGT-30) and a muta-
genic anti-sense primer, a-VWF-‘‘3675’’ (50-atctagaattcg3663GTGCT
CAGGGTCACTGG-30), containing an stop codon and an engineered
EcoRI site for cloning. The capitalized sequence is the normal VWF
sequence. The 985 base pair BamHI/EcoRI-digested PCR product
Figure 7. A Speculative Model of VWF Unfurling from Tubules to
Long Platelet-Recruiting Filaments
Upon exocytosis of a WPB (left, with VWF tubules), the propeptide
falls off as the pH rises, and the VWF multimer unfurls in a long fila-
ment to recruit platelets.was ligated to the 2800 base pair AvrII/BamHI fragment of
pVW198.1 and the 4695 base pair NheI/EcoRI fragment of pEGFP-
N1 to create pEGFP-D3, taking advantage of the NheI/AvrII compat-
ible cohesive ends. A similar strategy was used to create two addi-
tional vectors, pCMV-VWF-D3-c-myc, which contains a c-myc tag
rather than GFP, and pCIneo-VWF-D3, which does not contain a
c-myc epitope or GFP tag. The D1-A1 construct was obtained by us-
ing the full-length VWF expression vector, pCIneo-VWF-ES (previ-
ously described), as a template: an 851 base pair PCR product
was generated with primer s-VWF-3598 (50-GAGaTGcaTGGCCGG
CGTTTTGCCTCAGGA-30) and a-VWF 4449 min (50-CAAGAGCggC
cGctaCACAGTGACTTGTGC-30) to introduce a stop codon, followed
by a NotI restriction site at the 30 end of the construct. Normal VWF
sequence is indicated by uppercase letters. The resulting PCR prod-
uct was cloned into the Bsu36I/NotI site of the shuttle vector,
pG11vW1, that contains the BamHI/NotI fragment of pCIneo-VWF-
ES cloned into the pGEM-11 cloning vector (Promega). PG11vW1
was then digested with BamHI and NotI, and the resulting 1721
base pair fragment was ligated to the 2360 base pair XbaI/BamHI
and the 5806 base pair XbaI/NotI fragments of pCIneo-VWF-ES to
create pCIneo-VWF-A1.
GFP, Antibodies, and Microscopy
Sheep polyclonal anti-human VWF was purchased from Serotec
(Oxford, United Kingdom). The monoclonal anti-VWF-propeptide
239.1 has been described (Haberichter et al., 2000). Secondary anti-
bodies coupled to fluorophores were purchased from Jackson
(Luton, United Kingdom). FITC-labeled anti-mouse CD41 was pur-
chased from BD-Pharmingen (Oxford, United Kingdom). For immu-
nofluorescence studies, antibody staining and confocal microscopy
were carried out as previously described (Blagoveshchenskaya
et al., 2002). In Figure 1B, data were collected 48 hr after nucleofec-
tion and are projections of confocal sections throughout the cells.
While the figures of this paper generally show very few cells, great
care was taken to ensure that these are representative of the data.
Indeed, the drugs and detergent that were used had a very homog-
enous and reproducible effect.
Electron Microscopy
HUVECs were plated onto 10 or 13 mm diameter coverslips for em-
bedding en face. Cells were fixed in 2% paraformaldehyde/1.5%
glutaraldehyde in M199/20 mM HEPES. After monensin treatment,
cells were fixed with 2% paraformaldehyde/1.5% glutaraldehyde
in 0.1 M sodium cacodylate buffer or in M199/20 mM HEPES for 20
min at room temperature. The cells were then postfixed in 1% os-
mium tetroxide/1.5% potassium ferricyanide and treated with tannic
acid as described previously (Simionescu and Simionescu, 1976).
The samples were then embedded in epon by conventional proce-
dures. Coverslips were removed by plunging the samples into liquid
nitrogen, leaving the cells embedded on the epon. Sections (60 nm)
were then cut with a Leica Ultracut UCT microtome (Leica, Vienna,
Austria), stained with lead citrate, and viewed with a transmission
electron microscope (EM420; Philips, Eindhoven, the Netherlands).
Platelet Preparation
Venous blood was collected from healthy human adult volunteers
into acid-citrate-dextrose (ACD) anticoagulant. Blood was centri-
fuged at 200 3 g for 10 min to produce platelet-rich plasma (PRP).
PRP was collected and reacidified by the addition of ACD before
the platelets were pelleted by centrifugation at 300 3 g for 20 min.
Plasma was removed, and platelets were resuspended at 1 3 108/
ml in HEPES Tyrode buffer.
In Vitro Platelet String Formation
HUVECs were plated onto 35 mm Petri dishes and treated with 10
mM monensin or control for 1 hr. The Petri dishes were then incorpo-
rated into a parallel-plate chamber (Glycotech, MD, USA) and con-
nected to a syringe pump that drew fluid through the chamber at
a flow rate giving a wall shear stress of 0.25 Pa (2.5 dyn/cm2). The in-
let of the flow chamber was connected to an electronic valve allow-
ing switching between perfusions of histamine (Sigma; 100 mM in
HUVEC growth medium without plasma) or platelets and histamine.
The chamber was mounted on a phase-contrast video-microscope
(Nikon Eclipse TE300), enclosed at 37ºC.
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perfused across HUVECs for 11 min to stimulate VWF release; per-
fusion of platelets started 1 min after the histamine stimulation be-
gan. During this 10 min period, a series of fields were scanned and
recorded for later off-line analysis. Platelet strings could be visual-
ized directly and were also video recorded with a 1/200 3-CCD camera
(Hitachi HV-C20A, Hitachi Denshi, Leeds, UK) onto mini-DV cas-
settes. Video recordings were transferred to an Apple computer
and then analyzed with iMovie (Apple). Still pictures were then ex-
tracted and analyzed with Openlab (Improvision) to determine the
length of each individual platelet string (as defined by the cell from
which the filament originated to the last platelet attached to it) and
the number of platelets attached.
In Vivo Platelet String Formation
Male C57BL/6 mice (20–30 g) were purchased from Harlan. All pro-
cedures were approved by the University of Sheffield ethics commit-
tee and performed in accordance with Home Office Animals (Scien-
tific Procedures) Act 1986. Mice were anaesthetized and prepared
for intravital microscopy of the cremaster muscle as described (Nor-
man et al., 2000). Mice were either pretreated with intrascrotal mon-
ensin (200 ml; 100 mM in saline) prior to surgery or received a contin-
uous superfusion of 100 mM monensin directly onto the prepared
cremaster muscle for 30 min before microscopy began. During intra-
vital microscopy recording, the cremaster muscle was superfused
with thermocontrolled (36ºC) bicarbonate-buffered salt solution.
Cremaster venules and arterioles (20–50 mm) were observed with
a light microscope (Nikon Eclipse E600-FN, Nikon UK Ltd) equipped
with a water immersion objective (403/0.80 W). Endothelial injury
was induced in up to ten microvessels (venules and arterioles) per
animal by using a pulsed nitrogen dye laser (Photonic Instruments,
St. Charles, IL) applied through the microscope objective. Laser en-
ergy was attenuated to a lower level than typically required for
thrombus generation by using a variable neutral density filter, and
the laser was fired at a frequency of approximately 1 Hz until evi-
dence of string formation was detected (usually within 5 s). Images
were captured with a three chip 1/300 CCD camera (Dage MTI DC-
330, DAGE MTI, Inc., Michigan City, IN) and were recorded onto
mini-DV cassettes for later off-line analysis. Some mice received
5 mg anti-CD41 antibody to preferentially label platelets as described
(Falati et al., 2002). In these experiments, vessels were imaged in
brightfield and under fluorescence by using an automated excitation
filter changer (Lamba DG4, Sutter Novato, CA), an intensified (GenIII,
Videoscope, Dulles, VA) camera system (Sensicam, Cooke, Auburn
Hills, MI), and Slidebook software (Intelligent Imaging Innovations,
Denver, CO).
Sequences were captured onto an Apple G5 computer by using
Final Cut Pro software (Apple Computers Inc.) and were analyzed
with the public domain NIH-Image program (available on the internet
at http://rsb.info.nih.gov/nih-image). Platelet string length was mea-
sured from the point of endothelial injury to the farthest point of
platelet adhesion. String duration was determined as the time be-
tween initiation and termination of visible platelet interaction. Vessel
diameter, center-line velocity, and shear rate were determined as
described (Norman, 2001).
Supplemental Data
Supplemental Data including four figures and five movies are avail-
able at http://www.developmentalcell.com/cgi/content/full/10/2/
223/DC1/.
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